SUVRETTA CAPITAL MANAGEMENT, LLC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$13.26M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of SUVRETTA CAPITAL MANAGEMENT, LLC

According to the SEC Form 4 filings, SUVRETTA CAPITAL MANAGEMENT, LLC, being in a position of

  1. at Benitec Biopharma Inc.,
    оver the last 12 months, has bought 1671845 shares for $22.44M, and sold 0 shares,
    over all time since 2024-11-19, has bought 2719298 shares for $35.7M, and sold 0 shares.

Biography of SUVRETTA CAPITAL MANAGEMENT, LLC

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$22,442,0997100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2025-12-29PurchaseBenitec Biopharma Inc.
BNTC
77,387
0.3025%
$13.44$1.04M-12.56%
2025-12-26PurchaseBenitec Biopharma Inc.
BNTC
16,836
0.0641%
$13.10$220,552-9.92%
2025-12-23PurchaseBenitec Biopharma Inc.
BNTC
50,000
0.1982%
$12.85$642,500-8.64%
2025-12-22PurchaseBenitec Biopharma Inc.
BNTC
19,542
0.0728%
$12.08$236,067-4.13%
2025-12-19PurchaseBenitec Biopharma Inc.
BNTC
16,384
0.0623%
$11.48$188,088+2.96%
2025-12-18PurchaseBenitec Biopharma Inc.
BNTC
10,215
0.0384%
$11.24$114,817+4.04%
2025-11-07PurchaseBenitec Biopharma Inc.
BNTC
1.48M
4.657%
$13.50$20M-6.14%
2025-03-31PurchaseBenitec Biopharma Inc.
BNTC
16,497
0.0638%
$12.83$211,7360%
2025-03-26PurchaseBenitec Biopharma Inc.
BNTC
900,000
3.561%
$13.00$11.7M-7%
2024-12-24PurchaseBenitec Biopharma Inc.
BNTC
20,018
0.0838%
$11.25$225,203+13.69%
2024-12-23PurchaseBenitec Biopharma Inc.
BNTC
27,502
0.1165%
$10.98$301,972+17.13%
2024-12-03PurchaseBenitec Biopharma Inc.
BNTC
42,000
0.1737%
$9.60$403,200+31.4%
2024-11-20PurchaseBenitec Biopharma Inc.
BNTC
27,436
0.113%
$10.22$280,396+23.08%
2024-11-19PurchaseBenitec Biopharma Inc.
BNTC
14,000
0.0584%
$9.73$136,220+32.49%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.